Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015-2019).

Autor: Neofytos D; Geneva University Hospitals, Geneva, Switzerland., Pagliuca A; King's College London, London, UK., Houghton K; RTI Health Solutions, The Pavilion, Towers Business Park, Wilmslow Road, Didsbury, Manchester, M20 2LS, UK. kstull@rti.org., Broughton E; Pfizer Inc., New York, NY, USA., de Figueiredo Valente MLN; Pfizer Inc., Sao Paulo, Brazil., Jiang L; Pfizer Inc., New York, NY, USA., Enoch DA; Cambridge University Hospital NHS Foundation Trust, Cambridge, UK., Gruener B; University Hospital of Ulm, Ulm, Germany., Herbrecht R; Institut de Cancérologie Strasbourg Europe (ICANS), University of Strasbourg, Strasbourg, France., Lahmer T; Technical University of Munich, Munich, Germany., Lortholary O; Centre National de Référence Mycoses Invasives et Antifongiques, Necker Enfants Malades University Hospital and Institut Pasteur, Paris, France., Melenotte C; Necker Enfants Malades University Hospital, Paris, France., De Rosa FG; University of Turin, Turin, Italy., Garcia-Vidal C; Hospital Clinic Barcelona, Barcelona, Spain., Jimenez M; RTI Health Solutions, Research Triangle Park, NC, USA., Fernandez M; Pfizer Inc., New York, NY, USA., Cornely O; University of Cologne, Cologne, Germany.

Publikováno v: Infectious diseases and therapy [Infect Dis Ther] 2024 Oct 24. Date of Electronic Publication: 2024 Oct 24.